nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—ABCB1—peripheral nervous system neoplasm	0.371	1	CbGaD
Betamethasone—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.0499	0.144	CbGbCtD
Betamethasone—PTGS2—Etoposide—peripheral nervous system neoplasm	0.0491	0.142	CbGbCtD
Betamethasone—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0414	0.119	CbGbCtD
Betamethasone—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0414	0.119	CbGbCtD
Betamethasone—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0287	0.0828	CbGbCtD
Betamethasone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0248	0.0715	CbGbCtD
Betamethasone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.023	0.0665	CbGbCtD
Betamethasone—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0177	0.051	CbGbCtD
Betamethasone—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0165	0.0475	CbGbCtD
Betamethasone—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0162	0.0467	CbGbCtD
Betamethasone—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.011	0.0319	CbGbCtD
Betamethasone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0106	0.0305	CbGbCtD
Betamethasone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0097	0.028	CbGbCtD
Betamethasone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00661	0.0191	CbGbCtD
Betamethasone—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.000436	0.316	CrCbGaD
Betamethasone—Fluticasone furoate—ABCB1—peripheral nervous system neoplasm	0.000254	0.184	CrCbGaD
Betamethasone—NR3C2—ACE Inhibitor Pathway—KNG1—peripheral nervous system neoplasm	0.000227	0.0984	CbGpPWpGaD
Betamethasone—Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.000203	0.147	CrCbGaD
Betamethasone—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.000164	0.0712	CbGpPWpGaD
Betamethasone—Prednisone—ABCB1—peripheral nervous system neoplasm	0.000155	0.112	CrCbGaD
Betamethasone—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.000143	0.103	CrCbGaD
Betamethasone—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000122	0.000437	CcSEcCtD
Betamethasone—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000436	CcSEcCtD
Betamethasone—Migraine—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000436	CcSEcCtD
Betamethasone—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000436	CcSEcCtD
Betamethasone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000121	0.000434	CcSEcCtD
Betamethasone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000121	0.000434	CcSEcCtD
Betamethasone—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000121	0.000434	CcSEcCtD
Betamethasone—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000121	0.000432	CcSEcCtD
Betamethasone—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00012	0.00043	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00012	0.000429	CcSEcCtD
Betamethasone—Malaise—Etoposide—peripheral nervous system neoplasm	0.00012	0.000429	CcSEcCtD
Betamethasone—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00012	0.000429	CcSEcCtD
Betamethasone—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000429	CcSEcCtD
Betamethasone—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000119	0.000427	CcSEcCtD
Betamethasone—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000119	0.000425	CcSEcCtD
Betamethasone—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000118	0.000424	CcSEcCtD
Betamethasone—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000118	0.000424	CcSEcCtD
Betamethasone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000118	0.000424	CcSEcCtD
Betamethasone—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000118	0.000424	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000423	CcSEcCtD
Betamethasone—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000421	CcSEcCtD
Betamethasone—Infection—Cisplatin—peripheral nervous system neoplasm	0.000118	0.000421	CcSEcCtD
Betamethasone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000117	0.000421	CcSEcCtD
Betamethasone—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00042	CcSEcCtD
Betamethasone—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00042	CcSEcCtD
Betamethasone—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000117	0.000418	CcSEcCtD
Betamethasone—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000418	CcSEcCtD
Betamethasone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000116	0.000417	CcSEcCtD
Betamethasone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000116	0.000417	CcSEcCtD
Betamethasone—Rash—Topotecan—peripheral nervous system neoplasm	0.000116	0.000417	CcSEcCtD
Betamethasone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000116	0.000417	CcSEcCtD
Betamethasone—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000116	0.000417	CcSEcCtD
Betamethasone—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000416	CcSEcCtD
Betamethasone—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000415	CcSEcCtD
Betamethasone—Headache—Topotecan—peripheral nervous system neoplasm	0.000116	0.000415	CcSEcCtD
Betamethasone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000116	0.000414	CcSEcCtD
Betamethasone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000116	0.000414	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000116	0.000414	CcSEcCtD
Betamethasone—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000115	0.000414	CcSEcCtD
Betamethasone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000115	0.000413	CcSEcCtD
Betamethasone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000115	0.000413	CcSEcCtD
Betamethasone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000115	0.000413	CcSEcCtD
Betamethasone—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000115	0.000412	CcSEcCtD
Betamethasone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000115	0.000412	CcSEcCtD
Betamethasone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000115	0.000411	CcSEcCtD
Betamethasone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000115	0.000411	CcSEcCtD
Betamethasone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000115	0.000411	CcSEcCtD
Betamethasone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.00041	CcSEcCtD
Betamethasone—Pain—Vincristine—peripheral nervous system neoplasm	0.000114	0.00041	CcSEcCtD
Betamethasone—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.00041	CcSEcCtD
Betamethasone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000114	0.00041	CcSEcCtD
Betamethasone—Rash—Melphalan—peripheral nervous system neoplasm	0.000114	0.000409	CcSEcCtD
Betamethasone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000114	0.000408	CcSEcCtD
Betamethasone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.000407	CcSEcCtD
Betamethasone—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000406	CcSEcCtD
Betamethasone—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000113	0.000404	CcSEcCtD
Betamethasone—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000403	CcSEcCtD
Betamethasone—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000403	CcSEcCtD
Betamethasone—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000403	CcSEcCtD
Betamethasone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000112	0.0004	CcSEcCtD
Betamethasone—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000111	0.000396	CcSEcCtD
Betamethasone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000395	CcSEcCtD
Betamethasone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000393	CcSEcCtD
Betamethasone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000393	CcSEcCtD
Betamethasone—Nausea—Topotecan—peripheral nervous system neoplasm	0.00011	0.000393	CcSEcCtD
Betamethasone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000109	0.000392	CcSEcCtD
Betamethasone—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	0.000109	0.0791	CrCbGaD
Betamethasone—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000391	CcSEcCtD
Betamethasone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000109	0.00039	CcSEcCtD
Betamethasone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000109	0.00039	CcSEcCtD
Betamethasone—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.00039	CcSEcCtD
Betamethasone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000108	0.000388	CcSEcCtD
Betamethasone—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000388	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000386	CcSEcCtD
Betamethasone—Infection—Etoposide—peripheral nervous system neoplasm	0.000108	0.000386	CcSEcCtD
Betamethasone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000107	0.000385	CcSEcCtD
Betamethasone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000107	0.000385	CcSEcCtD
Betamethasone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000381	CcSEcCtD
Betamethasone—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000106	0.00038	CcSEcCtD
Betamethasone—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000106	0.000379	CcSEcCtD
Betamethasone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000106	0.000379	CcSEcCtD
Betamethasone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000106	0.000379	CcSEcCtD
Betamethasone—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000376	CcSEcCtD
Betamethasone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000105	0.000375	CcSEcCtD
Betamethasone—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000373	CcSEcCtD
Betamethasone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000103	0.00037	CcSEcCtD
Betamethasone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000103	0.000368	CcSEcCtD
Betamethasone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000102	0.000367	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000102	0.000366	CcSEcCtD
Betamethasone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000101	0.000363	CcSEcCtD
Betamethasone—Pain—Cisplatin—peripheral nervous system neoplasm	0.000101	0.000362	CcSEcCtD
Betamethasone—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000361	CcSEcCtD
Betamethasone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	9.96e-05	0.000357	CcSEcCtD
Betamethasone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	9.82e-05	0.000352	CcSEcCtD
Betamethasone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	9.75e-05	0.000349	CcSEcCtD
Betamethasone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	9.73e-05	0.000349	CcSEcCtD
Betamethasone—Weight increased—Epirubicin—peripheral nervous system neoplasm	9.72e-05	0.000348	CcSEcCtD
Betamethasone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	9.67e-05	0.000346	CcSEcCtD
Betamethasone—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	9.64e-05	0.000345	CcSEcCtD
Betamethasone—Asthenia—Vincristine—peripheral nervous system neoplasm	9.6e-05	0.000344	CcSEcCtD
Betamethasone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.52e-05	0.000341	CcSEcCtD
Betamethasone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	9.5e-05	0.00034	CcSEcCtD
Betamethasone—Rash—Dactinomycin—peripheral nervous system neoplasm	9.44e-05	0.000338	CcSEcCtD
Betamethasone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	9.42e-05	0.000338	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	9.36e-05	0.000335	CcSEcCtD
Betamethasone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	9.35e-05	0.000335	CcSEcCtD
Betamethasone—Fatigue—Etoposide—peripheral nervous system neoplasm	9.34e-05	0.000335	CcSEcCtD
Betamethasone—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	9.34e-05	0.000335	CcSEcCtD
Betamethasone—Pain—Etoposide—peripheral nervous system neoplasm	9.27e-05	0.000332	CcSEcCtD
Betamethasone—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	9.26e-05	0.000332	CcSEcCtD
Betamethasone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	9.18e-05	0.000329	CcSEcCtD
Betamethasone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	9.15e-05	0.000328	CcSEcCtD
Betamethasone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	9e-05	0.000322	CcSEcCtD
Betamethasone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	8.94e-05	0.00032	CcSEcCtD
Betamethasone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	8.93e-05	0.00032	CcSEcCtD
Betamethasone—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	8.92e-05	0.000319	CcSEcCtD
Betamethasone—Nausea—Dactinomycin—peripheral nervous system neoplasm	8.9e-05	0.000319	CcSEcCtD
Betamethasone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	8.86e-05	0.000318	CcSEcCtD
Betamethasone—Dizziness—Vincristine—peripheral nervous system neoplasm	8.85e-05	0.000317	CcSEcCtD
Betamethasone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	8.83e-05	0.000316	CcSEcCtD
Betamethasone—Rash—Alitretinoin—peripheral nervous system neoplasm	8.76e-05	0.000314	CcSEcCtD
Betamethasone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	8.75e-05	0.000313	CcSEcCtD
Betamethasone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	8.71e-05	0.000312	CcSEcCtD
Betamethasone—Headache—Alitretinoin—peripheral nervous system neoplasm	8.7e-05	0.000312	CcSEcCtD
Betamethasone—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	8.64e-05	0.00031	CcSEcCtD
Betamethasone—Urticaria—Etoposide—peripheral nervous system neoplasm	8.61e-05	0.000308	CcSEcCtD
Betamethasone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	8.6e-05	0.000308	CcSEcCtD
Betamethasone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.57e-05	0.000307	CcSEcCtD
Betamethasone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	8.57e-05	0.000307	CcSEcCtD
Betamethasone—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	8.57e-05	0.000307	CcSEcCtD
Betamethasone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	8.55e-05	0.000306	CcSEcCtD
Betamethasone—Vomiting—Vincristine—peripheral nervous system neoplasm	8.51e-05	0.000305	CcSEcCtD
Betamethasone—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.49e-05	0.000304	CcSEcCtD
Betamethasone—Rash—Vincristine—peripheral nervous system neoplasm	8.44e-05	0.000302	CcSEcCtD
Betamethasone—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.43e-05	0.000302	CcSEcCtD
Betamethasone—Headache—Vincristine—peripheral nervous system neoplasm	8.38e-05	0.0003	CcSEcCtD
Betamethasone—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.25e-05	0.000295	CcSEcCtD
Betamethasone—Visual impairment—Epirubicin—peripheral nervous system neoplasm	8.24e-05	0.000295	CcSEcCtD
Betamethasone—Dexamethasone—ABCB1—peripheral nervous system neoplasm	8.14e-05	0.0589	CrCbGaD
Betamethasone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.09e-05	0.00029	CcSEcCtD
Betamethasone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	8.06e-05	0.000289	CcSEcCtD
Betamethasone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	7.99e-05	0.000286	CcSEcCtD
Betamethasone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	7.95e-05	0.000285	CcSEcCtD
Betamethasone—Nausea—Vincristine—peripheral nervous system neoplasm	7.95e-05	0.000285	CcSEcCtD
Betamethasone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	7.91e-05	0.000283	CcSEcCtD
Betamethasone—Asthenia—Etoposide—peripheral nervous system neoplasm	7.78e-05	0.000279	CcSEcCtD
Betamethasone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.000278	CcSEcCtD
Betamethasone—Pruritus—Etoposide—peripheral nervous system neoplasm	7.67e-05	0.000275	CcSEcCtD
Betamethasone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000274	CcSEcCtD
Betamethasone—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	7.63e-05	0.000273	CcSEcCtD
Betamethasone—PLA2G1B—Glycerophospholipid biosynthesis—BCHE—peripheral nervous system neoplasm	7.57e-05	0.0329	CbGpPWpGaD
Betamethasone—Alopecia—Epirubicin—peripheral nervous system neoplasm	7.56e-05	0.000271	CcSEcCtD
Betamethasone—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.52e-05	0.000269	CcSEcCtD
Betamethasone—Rash—Cisplatin—peripheral nervous system neoplasm	7.46e-05	0.000267	CcSEcCtD
Betamethasone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.45e-05	0.000267	CcSEcCtD
Betamethasone—Erythema—Epirubicin—peripheral nervous system neoplasm	7.44e-05	0.000267	CcSEcCtD
Betamethasone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.42e-05	0.000266	CcSEcCtD
Betamethasone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	7.39e-05	0.000265	CcSEcCtD
Betamethasone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000257	CcSEcCtD
Betamethasone—Dizziness—Etoposide—peripheral nervous system neoplasm	7.17e-05	0.000257	CcSEcCtD
Betamethasone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.000253	CcSEcCtD
Betamethasone—Nausea—Cisplatin—peripheral nervous system neoplasm	7.03e-05	0.000252	CcSEcCtD
Betamethasone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000251	CcSEcCtD
Betamethasone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.91e-05	0.000247	CcSEcCtD
Betamethasone—Vomiting—Etoposide—peripheral nervous system neoplasm	6.89e-05	0.000247	CcSEcCtD
Betamethasone—Erythema—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000247	CcSEcCtD
Betamethasone—Rash—Etoposide—peripheral nervous system neoplasm	6.83e-05	0.000245	CcSEcCtD
Betamethasone—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.83e-05	0.000245	CcSEcCtD
Betamethasone—Headache—Etoposide—peripheral nervous system neoplasm	6.79e-05	0.000243	CcSEcCtD
Betamethasone—Malaise—Epirubicin—peripheral nervous system neoplasm	6.71e-05	0.000241	CcSEcCtD
Betamethasone—Vertigo—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.00024	CcSEcCtD
Betamethasone—Syncope—Epirubicin—peripheral nervous system neoplasm	6.68e-05	0.000239	CcSEcCtD
Betamethasone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6.54e-05	0.000234	CcSEcCtD
Betamethasone—Convulsion—Epirubicin—peripheral nervous system neoplasm	6.45e-05	0.000231	CcSEcCtD
Betamethasone—Nausea—Etoposide—peripheral nervous system neoplasm	6.44e-05	0.000231	CcSEcCtD
Betamethasone—Hypertension—Epirubicin—peripheral nervous system neoplasm	6.43e-05	0.00023	CcSEcCtD
Betamethasone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.39e-05	0.000229	CcSEcCtD
Betamethasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—peripheral nervous system neoplasm	6.38e-05	0.0277	CbGpPWpGaD
Betamethasone—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.000227	CcSEcCtD
Betamethasone—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.32e-05	0.000226	CcSEcCtD
Betamethasone—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.26e-05	0.000224	CcSEcCtD
Betamethasone—Malaise—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000223	CcSEcCtD
Betamethasone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.000222	CcSEcCtD
Betamethasone—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.18e-05	0.000221	CcSEcCtD
Betamethasone—Oedema—Epirubicin—peripheral nervous system neoplasm	6.08e-05	0.000218	CcSEcCtD
Betamethasone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	6.08e-05	0.000218	CcSEcCtD
Betamethasone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.05e-05	0.000217	CcSEcCtD
Betamethasone—Infection—Epirubicin—peripheral nervous system neoplasm	6.04e-05	0.000216	CcSEcCtD
Betamethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	6.03e-05	0.0262	CbGpPWpGaD
Betamethasone—Shock—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.000214	CcSEcCtD
Betamethasone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	5.97e-05	0.000214	CcSEcCtD
Betamethasone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000213	CcSEcCtD
Betamethasone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.95e-05	0.000213	CcSEcCtD
Betamethasone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.000213	CcSEcCtD
Betamethasone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	5.93e-05	0.000212	CcSEcCtD
Betamethasone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.00021	CcSEcCtD
Betamethasone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.00021	CcSEcCtD
Betamethasone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.84e-05	0.000209	CcSEcCtD
Betamethasone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.79e-05	0.000208	CcSEcCtD
Betamethasone—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.000207	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	5.72e-05	0.0249	CbGpPWpGaD
Betamethasone—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.68e-05	0.000203	CcSEcCtD
Betamethasone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.62e-05	0.000201	CcSEcCtD
Betamethasone—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.62e-05	0.000201	CcSEcCtD
Betamethasone—Infection—Doxorubicin—peripheral nervous system neoplasm	5.58e-05	0.0002	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000198	CcSEcCtD
Betamethasone—Shock—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000198	CcSEcCtD
Betamethasone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.51e-05	0.000198	CcSEcCtD
Betamethasone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000197	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	5.5e-05	0.0239	CbGpPWpGaD
Betamethasone—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.5e-05	0.000197	CcSEcCtD
Betamethasone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000197	CcSEcCtD
Betamethasone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000195	CcSEcCtD
Betamethasone—CYP19A1—FSH signaling pathway—BDNF—peripheral nervous system neoplasm	5.45e-05	0.0237	CbGpPWpGaD
Betamethasone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000195	CcSEcCtD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—PTPN11—peripheral nervous system neoplasm	5.42e-05	0.0235	CbGpPWpGaD
Betamethasone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000192	CcSEcCtD
Betamethasone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.35e-05	0.000192	CcSEcCtD
Betamethasone—PLA2G1B—Phospholipid metabolism—BCHE—peripheral nervous system neoplasm	5.28e-05	0.023	CbGpPWpGaD
Betamethasone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.000189	CcSEcCtD
Betamethasone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000188	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.000188	CcSEcCtD
Betamethasone—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.24e-05	0.000188	CcSEcCtD
Betamethasone—Pain—Epirubicin—peripheral nervous system neoplasm	5.2e-05	0.000186	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000183	CcSEcCtD
Betamethasone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.08e-05	0.000182	CcSEcCtD
Betamethasone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000181	CcSEcCtD
Betamethasone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000179	CcSEcCtD
Betamethasone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.97e-05	0.000178	CcSEcCtD
Betamethasone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.95e-05	0.000177	CcSEcCtD
Betamethasone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.000175	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000174	CcSEcCtD
Betamethasone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000174	CcSEcCtD
Betamethasone—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000173	CcSEcCtD
Betamethasone—Pain—Doxorubicin—peripheral nervous system neoplasm	4.81e-05	0.000172	CcSEcCtD
Betamethasone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.8e-05	0.000172	CcSEcCtD
Betamethasone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.8e-05	0.000172	CcSEcCtD
Betamethasone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000166	CcSEcCtD
Betamethasone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.6e-05	0.000165	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.6e-05	0.02	CbGpPWpGaD
Betamethasone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.00016	CcSEcCtD
Betamethasone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.000159	CcSEcCtD
Betamethasone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.000159	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	4.41e-05	0.0192	CbGpPWpGaD
Betamethasone—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.000156	CcSEcCtD
Betamethasone—PGR—Nuclear signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	4.31e-05	0.0188	CbGpPWpGaD
Betamethasone—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.3e-05	0.000154	CcSEcCtD
Betamethasone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000149	CcSEcCtD
Betamethasone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	4.14e-05	0.018	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	4.13e-05	0.0179	CbGpPWpGaD
Betamethasone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000145	CcSEcCtD
Betamethasone—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.02e-05	0.000144	CcSEcCtD
Betamethasone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.000142	CcSEcCtD
Betamethasone—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.86e-05	0.000138	CcSEcCtD
Betamethasone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000138	CcSEcCtD
Betamethasone—Rash—Epirubicin—peripheral nervous system neoplasm	3.83e-05	0.000137	CcSEcCtD
Betamethasone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.83e-05	0.000137	CcSEcCtD
Betamethasone—Headache—Epirubicin—peripheral nervous system neoplasm	3.81e-05	0.000136	CcSEcCtD
Betamethasone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.72e-05	0.000133	CcSEcCtD
Betamethasone—Nausea—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000129	CcSEcCtD
Betamethasone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.57e-05	0.000128	CcSEcCtD
Betamethasone—Rash—Doxorubicin—peripheral nervous system neoplasm	3.54e-05	0.000127	CcSEcCtD
Betamethasone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.54e-05	0.000127	CcSEcCtD
Betamethasone—Headache—Doxorubicin—peripheral nervous system neoplasm	3.52e-05	0.000126	CcSEcCtD
Betamethasone—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	3.51e-05	0.0153	CbGpPWpGaD
Betamethasone—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.00012	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.03e-05	0.0132	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	2.75e-05	0.012	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	2.72e-05	0.0118	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	2.55e-05	0.0111	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	2.47e-05	0.0107	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—EED—peripheral nervous system neoplasm	2.41e-05	0.0105	CbGpPWpGaD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—HRAS—peripheral nervous system neoplasm	2.38e-05	0.0104	CbGpPWpGaD
Betamethasone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	2.26e-05	0.00984	CbGpPWpGaD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—AKT1—peripheral nervous system neoplasm	2.1e-05	0.00914	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.05e-05	0.0089	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—SUZ12—peripheral nervous system neoplasm	1.93e-05	0.00837	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	1.86e-05	0.00809	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	1.84e-05	0.00801	CbGpPWpGaD
Betamethasone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	1.78e-05	0.00773	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.7e-05	0.00739	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.68e-05	0.0073	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	1.65e-05	0.00716	CbGpPWpGaD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	1.63e-05	0.00707	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	1.58e-05	0.00688	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	1.57e-05	0.00684	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GNS—peripheral nervous system neoplasm	1.48e-05	0.00643	CbGpPWpGaD
Betamethasone—CYP19A1—FSH signaling pathway—AKT1—peripheral nervous system neoplasm	1.47e-05	0.00641	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—EED—peripheral nervous system neoplasm	1.47e-05	0.00637	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	1.45e-05	0.00632	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	1.45e-05	0.0063	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—NME1—peripheral nervous system neoplasm	1.42e-05	0.00617	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—COX2—peripheral nervous system neoplasm	1.37e-05	0.00594	CbGpPWpGaD
Betamethasone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	1.37e-05	0.00593	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	1.32e-05	0.00574	CbGpPWpGaD
Betamethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	1.3e-05	0.00565	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	1.29e-05	0.00561	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	1.18e-05	0.00513	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—SUZ12—peripheral nervous system neoplasm	1.17e-05	0.0051	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—ERBB2—peripheral nervous system neoplasm	1.15e-05	0.00499	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.12e-05	0.00487	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	1.12e-05	0.00486	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—peripheral nervous system neoplasm	1.11e-05	0.00483	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.11e-05	0.00481	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	9.96e-06	0.00433	CbGpPWpGaD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	9.48e-06	0.00412	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	9.28e-06	0.00403	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	9.12e-06	0.00396	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—ENO2—peripheral nervous system neoplasm	8.97e-06	0.0039	CbGpPWpGaD
Betamethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	8.8e-06	0.00382	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	8.75e-06	0.0038	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	8.74e-06	0.0038	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—EED—peripheral nervous system neoplasm	8.48e-06	0.00368	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	8.46e-06	0.00367	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	8.32e-06	0.00361	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	7.78e-06	0.00338	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	7.61e-06	0.00331	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—BCHE—peripheral nervous system neoplasm	7.58e-06	0.00329	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	7.49e-06	0.00325	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.48e-06	0.00325	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.4e-06	0.00321	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	7.29e-06	0.00317	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.23e-06	0.00314	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	7.18e-06	0.00312	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—TH—peripheral nervous system neoplasm	7.12e-06	0.0031	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.89e-06	0.003	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	6.87e-06	0.00299	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SUZ12—peripheral nervous system neoplasm	6.78e-06	0.00295	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.61e-06	0.00287	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	6.47e-06	0.00281	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	6.39e-06	0.00278	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—peripheral nervous system neoplasm	6.33e-06	0.00275	CbGpPWpGaD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	6.25e-06	0.00272	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.21e-06	0.0027	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	6.15e-06	0.00267	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	5.9e-06	0.00256	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	5.9e-06	0.00256	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GNAS—peripheral nervous system neoplasm	5.82e-06	0.00253	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	5.73e-06	0.00249	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—ABCB1—peripheral nervous system neoplasm	5.71e-06	0.00248	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	5.64e-06	0.00245	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	5.59e-06	0.00243	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	5.53e-06	0.0024	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	5.46e-06	0.00237	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GNS—peripheral nervous system neoplasm	5.41e-06	0.00235	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	5.4e-06	0.00235	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	5.4e-06	0.00235	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	5.36e-06	0.00233	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	5.35e-06	0.00232	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.24e-06	0.00228	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.22e-06	0.00227	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NME1—peripheral nervous system neoplasm	5.18e-06	0.00225	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.04e-06	0.00219	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	5e-06	0.00217	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—COX2—peripheral nervous system neoplasm	4.99e-06	0.00217	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.82e-06	0.0021	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	4.5e-06	0.00196	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	4.41e-06	0.00191	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	4.37e-06	0.0019	CbGpPWpGaD
Betamethasone—PTGS2—Disease—GNS—peripheral nervous system neoplasm	4.31e-06	0.00187	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	4.19e-06	0.00182	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.15e-06	0.0018	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.8e-06	0.00165	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.72e-06	0.00162	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.62e-06	0.00157	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	3.61e-06	0.00157	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	3.59e-06	0.00156	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.54e-06	0.00154	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	3.46e-06	0.0015	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.42e-06	0.00148	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	3.37e-06	0.00146	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	3.33e-06	0.00145	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ENO2—peripheral nervous system neoplasm	3.27e-06	0.00142	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.23e-06	0.0014	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.1e-06	0.00135	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	3.02e-06	0.00131	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.97e-06	0.00129	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.97e-06	0.00129	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.95e-06	0.00128	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—BCHE—peripheral nervous system neoplasm	2.77e-06	0.0012	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.71e-06	0.00118	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.7e-06	0.00117	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.67e-06	0.00116	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MYC—peripheral nervous system neoplasm	2.66e-06	0.00116	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.64e-06	0.00115	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	2.61e-06	0.00114	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TH—peripheral nervous system neoplasm	2.6e-06	0.00113	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	2.56e-06	0.00111	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.45e-06	0.00107	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.44e-06	0.00106	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	2.36e-06	0.00103	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	2.19e-06	0.000951	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.18e-06	0.000948	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.15e-06	0.000933	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GNAS—peripheral nervous system neoplasm	2.12e-06	0.000923	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	2.11e-06	0.000915	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.11e-06	0.000915	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.08e-06	0.000906	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.06e-06	0.000895	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.95e-06	0.000846	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.88e-06	0.000818	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	1.85e-06	0.000803	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—peripheral nervous system neoplasm	1.85e-06	0.000802	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.76e-06	0.000766	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	1.74e-06	0.000755	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.73e-06	0.000751	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MYC—peripheral nervous system neoplasm	1.62e-06	0.000705	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.58e-06	0.000685	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—peripheral nervous system neoplasm	1.57e-06	0.000682	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.55e-06	0.000674	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.51e-06	0.000657	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.49e-06	0.000647	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.46e-06	0.000634	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.46e-06	0.000633	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	1.42e-06	0.000617	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.39e-06	0.000605	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.35e-06	0.000587	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.31e-06	0.00057	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.25e-06	0.000543	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.23e-06	0.000535	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	1.18e-06	0.000512	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.13e-06	0.000492	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—peripheral nervous system neoplasm	1.12e-06	0.000489	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.05e-06	0.000458	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	1.01e-06	0.000437	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	9.56e-07	0.000415	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MYC—peripheral nervous system neoplasm	9.37e-07	0.000407	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	9.31e-07	0.000404	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.66e-07	0.000376	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.28e-07	0.00036	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	8.07e-07	0.000351	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.7e-07	0.000335	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	7.59e-07	0.00033	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.31e-07	0.000318	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	7.08e-07	0.000308	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MYC—peripheral nervous system neoplasm	6.6e-07	0.000287	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—peripheral nervous system neoplasm	6.5e-07	0.000282	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	6.2e-07	0.000269	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	6.08e-07	0.000264	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—peripheral nervous system neoplasm	5.73e-07	0.000249	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	5.18e-07	0.000225	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	4.57e-07	0.000199	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	3.83e-07	0.000166	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.72e-07	0.000118	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.67e-07	7.27e-05	CbGpPWpGaD
